Retraction
Dexmedetomidine Inhibits Osteosarcoma Cell Proliferation and Migration, and Promotes Apoptosis by Regulating miR-520a-3p
Paper Information
Record ID:
24701
Author(s):
Journal:
Publication Date:
April 10, 2018
Retraction Date:
October 01, 2020
(5.1 years years ago)
Subjects:
Institutions:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Cognizant Communication Corporation
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.3727/096504017X14982578608217Additional Notes:
see also: https://scienceintegritydigest.com/2020/02/21/the-tadpole-paper-mill/; see also: https://pubpeer.com/publications/9ABAC96A8D53DDF08D52E436D219BE;
Citations (30)
30
Total Citations13
Post-Retraction(43.3%)
17
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
6
Within 1 year
3
After 2+ years
1718
Days since retraction (latest)
Mechanism of dexmedetomidine in inhibiting proliferation, migration, and invasion of esophageal squamous cell carcinoma cell through coagulation factor II receptor
Jianli Cui, Xiang Liu, Yanqin Liu et al. (4 authors)
Discover Oncology
Open Access
Published: Jun 2025
1718 days after retraction
Study on the effects of intraoperative administration of dexmedetomidine on the prognosis and survival outcomes of patients with colorectal cancer
Chu Ren, Ying Zeng, Liuji Qiu et al. (7 authors)
Heliyon
Open Access
Published: Sep 2024
3 citations
3 citations
1451 days after retraction
MiRNA-520a-3p combined with folic acid conjugated Fe<sub>2</sub>O<sub>3</sub>@PDA multifunctional nanoagents for MR imagine and antitumor gene-photothermal therapy
Xue Li, Shuang Wang, Qingzhe Gao et al. (9 authors)
Nanotechnology
Published: May 2023
9 citations
9 citations
957 days after retraction
Volatile and Intravenous Anesthetics and Cancer
Julia Dubowitz, Sanketh Rampes, Mats Enlund et al. (4 authors)
Elsevier eBooks
Published: Jul 2022
652 days after retraction
The Role of Dexmedetomidine in Tumor-Progressive Factors in the Perioperative Period and Cancer Recurrence: A Narrative Review
Qiang Cai, Guoqing Liu, Linsheng Huang et al. (9 authors)
Drug Design Development and Therapy
Open Access
Published: Jul 2022
15 citations
15 citations
638 days after retraction
Long non-coding RNA TTTY15 sponges miR-520a-3p to exacerbate neural apoptosis induced by cerebral ischemia/reperfusion via targeting IRF9 both in vivo and in vitro
Huan Wang, Hui Yang, Mingxiu Chang et al. (6 authors)
Biomedical Journal
Open Access
Published: Apr 2022
5 citations
5 citations
562 days after retraction
Dexmedetomidine promotes apoptosis and suppresses proliferation of hepatocellular carcinoma cells via microRNA-130a/EGR1 axis
Lei Zhou, Juanni Li, Xing Liu et al. (10 authors)
Cell Death Discovery
Open Access
Published: Jan 2022
8 citations
8 citations
475 days after retraction
Dexmedetomidine Inhibited Proliferation and Invasion of Cervical Cancer Cells by Inhibiting the Janus Tyrosine Kinase/Signal Transducer and Activator of Transcription Signaling Pathway
Fenlan Xu, Liying Xu, Xiaoyan Xu et al. (5 authors)
Journal of Biomaterials and Tissue Engineering
Published: Jul 2021
1 citation
1 citation
273 days after retraction
Piperine treating sciatica through regulating inflammation and MiR-520a/P65 pathway
Jiuwang Yu, Sha Li, Lidao Bao et al. (4 authors)
Chinese Journal of Natural Medicines
Published: Jun 2021
13 citations
13 citations
243 days after retraction
Dexmedetomidine upregulates microRNA-185 to suppress ovarian cancer growth via inhibiting the SOX9/Wnt/β-catenin signaling pathway
Hang Tian, Lei Hou, Yumei Xiong et al. (4 authors)
Cell Cycle
Open Access
Published: Apr 2021
21 citations
21 citations
185 days after retraction
miR‑302c‑3p and miR‑520a‑3p suppress the proliferation of cervical carcinoma cells by targeting CXCL8
Hongmei Ding, Hong Zhang, Juan Wang et al. (8 authors)
Molecular Medicine Reports
Open Access
Published: Mar 2021
14 citations
14 citations
155 days after retraction
Dexmedetomidine inhibits cell malignancy in osteosarcoma cells via miR-520a-3p-YOD1 interactome
Rongrong Yan, Shuangfen Jin, Hongchao Liu et al. (8 authors)
Biochemical and Biophysical Research Communications
Published: Jan 2021
13 citations
13 citations
118 days after retraction
Depletion of circRNA circ_CDK14 inhibits osteosarcoma progression by regulating the miR-520a-3p/GAB1 axis
Pengfei Wu, Xiaoming Tang, Hailang Sun et al. (6 authors)
Neoplasma
Open Access
Published: Jan 2021
6 citations
6 citations
92 days after retraction
Dexmedetomidine Provides Protection Against Hippocampal Neuron Apoptosis and Cognitive Impairment in Mice with Alzheimer’s Disease by Mediating the miR-129/YAP1/JAG1 Axis
Weiying Sun, Jun Zhao, Chunzhi Li
Molecular Neurobiology
Published: Aug 2020
61 citations
61 citations
38 days before retraction
Exosomal lncRNA H19 promotes the progression of hepatocellular carcinoma treated with Propofol via miR‐520a‐3p/LIMK1 axis
Dongmei Wang, Na Xing, Tao Yang et al. (8 authors)
Cancer Medicine
Open Access
Published: Aug 2020
58 citations
58 citations
55 days before retraction
<p>Ropivacaine Inhibits the Growth, Migration and Invasion of Gastric Cancer Through Attenuation of WEE1 and PI3K/AKT Signaling via miR-520a-3p</p>
Nianliang Zhang, Xiangji Xing, Fengcai Gu et al. (6 authors)
OncoTargets and Therapy
Open Access
Published: Jun 2020
29 citations
29 citations
122 days before retraction
Dexmedetomidine mediates microRNA-185 to suppress ovarian cancer growth via inhibiting the SOX9/Wnt/β-catenin signaling pathway
Hang Tian, Lei Hou, Yumei Xiong et al. (4 authors)
bioRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Apr 2020
168 days before retraction
Dexmedetomidine inhibits the invasion, migration, and inflammation of rheumatoid arthritis fibroblast-like synoviocytes by reducing the expression of NLRC5
Yaru Ji, Yu Chen, Yanni Chen et al. (10 authors)
International Immunopharmacology
Published: Mar 2020
17 citations
17 citations
206 days before retraction
RETRACTED ARTICLE: Upregulation of microRNA-204 improves insulin resistance of polycystic ovarian syndrome via inhibition of HMGB1 and the inactivation of the TLR4/NF-κB pathway
Bin Jiang, Min Xue, Dabao Xu et al. (5 authors)
Cell Cycle
Open Access
Published: Feb 2020
13 citations
13 citations
221 days before retraction
RETRACTED ARTICLE: Silencing of PTEN inhibits the oxidative stress damage and hippocampal cell apoptosis induced by Sevoflurane through activating MEK1/ERK signaling pathway in infant rats
Tiejun Liu, Xiaoliu Dong, Bin Wang et al. (8 authors)
Cell Cycle
Open Access
Published: Feb 2020
8 citations
8 citations
221 days before retraction
MicroRNA-561 Affects Proliferation and Cell Cycle Transition Through PTEN/AKT Signaling Pathway by Targeting P-REX2a in NSCLC
Zijun Liao, Qi Zheng, Ting Wei et al. (8 authors)
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
Open Access
Published: Nov 2019
18 citations
18 citations
324 days before retraction
Effects of dexmedetomidine on glioma cells in the presence or absence of cisplatin
Hui Yang, Yudan Chen, Hui Yan et al. (4 authors)
Journal of Cellular Biochemistry
Open Access
Published: Aug 2019
4 citations
4 citations
402 days before retraction
<p>miR520a-3p suppresses cell proliferation and metastasis by inhibiting the p65–NFκB pathway in glioblastoma</p>
Jingquan Zhang, Bo Hong
OncoTargets and Therapy
Open Access
Published: Aug 2019
2 citations
2 citations
427 days before retraction
Upregulation of microRNA‑520a‑3p inhibits the proliferation, migration and invasion via spindle and kinetochore associated 2 in gastric cancer
Hui Su, Feng Ren, Haitao Jiang et al. (5 authors)
Oncology Letters
Open Access
Published: Jul 2019
30 citations
30 citations
434 days before retraction
MicroRNA‐374c‐5p inhibits the development of breast cancer through TATA‐box binding protein associated factor 7‐mediated transcriptional regulation of DEP domain containing 1
Shuai Hao, Wuguo Tian, Yi Chen et al. (7 authors)
Journal of Cellular Biochemistry
Open Access
Published: Jun 2019
23 citations
23 citations
485 days before retraction
miRNA signatures in childhood sarcomas and their clinical implications
G. M. Viera, Karina Bezerra Salomão, Graziella Ribeiro de Sousa et al. (7 authors)
Clinical & Translational Oncology
Published: Apr 2019
15 citations
15 citations
546 days before retraction
Proliferation and Migration of Lung Cancer Could be Inhibited by Oxymatrine through the Regulation for miR-520/VEGF
Wen Zhou, Yunshan Wu, Miao Pan et al. (5 authors)
The American Journal of Chinese Medicine
Published: Jan 2019
36 citations
36 citations
639 days before retraction
RETRACTED: LINC01116 targets miR-520a-3p and affects IL6R to promote the proliferation and migration of osteosarcoma cells through the Jak-stat signaling pathway
Butian Zhang, Lili Yu, Ning Han et al. (7 authors)
Biomedicine & Pharmacotherapy
Published: Aug 2018
55 citations
55 citations
785 days before retraction
Deep RNA sequencing reveals the dynamic regulation of miRNA, lncRNAs, and mRNAs in osteosarcoma tumorigenesis and pulmonary metastasis
Lin Xie, Zhihong Yao, Ya Zhang et al. (13 authors)
Cell Death and Disease
Open Access
Published: Jul 2018
68 citations
68 citations
814 days before retraction
Midazolam induces A549 cell apoptosis in vitro via the miR-520d-5p/STAT3 pathway.
Jinghua Jiao, Yuheng Wang, Xiaofeng Sun et al. (4 authors)
PubMed
Published: Jan 2018
15 citations
15 citations
1004 days before retraction
Quick Stats
Total Citations:
30
Years Since Retraction:
5.1 years
Open Access:
Yes
Last Checked:
Jul 24, 2025